CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 4 Shares withheld for taxes President and CEO gave up 12,657 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 5,576 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 6,310 shares (to pay taxes)
- 8-K Event Regulation FD disclosure · Other events
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award President and CEO acquired 128,750 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 54,500 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 45,500 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 47,750 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
Page 18 of 24 · 464 filings